![]()
GONUTS is under stress! The website is currently experiencing long-wait times and frequent time-outs due to the record number of students, groups, and annotations related to CACAO this semester. We are currently working on increasing performance -- please accept our apologies for the technical difficulties.
You can help reduce stress on the server by:
- not reloading pages frequently - this just adds
- opening links in new windows (so you can read the old page)
MOUSE:TNAP3
Contents |
| Species (Taxon ID) | Mus musculus (Mouse). (taxon:10090) | |
| Gene Name(s) | Tnfaip3 ( synonyms: Tnfip3 ) | |
| Protein Name(s) |
| |
| External Links | ||
| UniProt Identifier | TNAP3_MOUSE | |
| UniProt Accessions | Q60769, Q3U968, | |
| EMBL | U19463, AK151921, | |
| PIR | I49237, | |
| IntAct | Q60769, | |
| Ensembl | ENSMUST00000019997, ENSMUST00000105527, | |
| Pfam | PF02338, PF01754, | |
Annotations
| Qualifier | GO ID | GO term name | Reference | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0001922 |
B-1 B cell homeostasis |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0002237 |
response to molecule of bacterial origin |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0002315 |
marginal zone B cell differentiation |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0002632 |
negative regulation of granuloma formation |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0002634 |
regulation of germinal center formation |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0002637 |
regulation of immunoglobulin production |
IC: Inferred by Curator |
GO:0001922 |
P |
||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003824 |
catalytic activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0004221 |
ubiquitin thiolesterase activity |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
F |
||||
| GO:0004221 |
ubiquitin thiolesterase activity |
ISS: Inferred from Sequence or Structural Similarity |
F |
|||||
| GO:0004842 |
ubiquitin-protein ligase activity |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
F |
||||
| GO:0004842 |
ubiquitin-protein ligase activity |
ISS: Inferred from Sequence or Structural Similarity |
F |
|||||
| GO:0004843 |
ubiquitin-specific protease activity |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
F |
||||
| GO:0004843 |
ubiquitin-specific protease activity |
ISS: Inferred from Sequence or Structural Similarity |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
C |
||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0191 |
C |
||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
C |
||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0086 |
C |
||||
| GO:0005737 |
cytoplasm |
IDA: Inferred from Direct Assay |
|
C |
||||
| GO:0005813 |
centrosome |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
C |
||||
| GO:0006915 |
apoptosis |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006916 |
anti-apoptosis |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0008152 |
metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0008233 |
peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008234 |
cysteine-type peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008270 |
zinc ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0009611 |
response to wounding |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0010507 |
negative regulation of autophagy |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0016579 |
protein deubiquitination |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0016787 |
hydrolase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0016874 |
ligase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0019900 |
kinase binding |
IDA: Inferred from Direct Assay |
|
F |
||||
| GO:0032495 |
response to muramyl dipeptide |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0032691 |
negative regulation of interleukin-1 beta production |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0032691 |
negative regulation of interleukin-1 beta production |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0032715 |
negative regulation of interleukin-6 production |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0032715 |
negative regulation of interleukin-6 production |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0032715 |
negative regulation of interleukin-6 production |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0032720 |
negative regulation of tumor necrosis factor production |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0034115 |
negative regulation of heterotypic cell-cell adhesion |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0034115 |
negative regulation of heterotypic cell-cell adhesion |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0034148 |
negative regulation of toll-like receptor 5 signaling pathway |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
P |
||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0043154 |
negative regulation of caspase activity |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0045088 |
regulation of innate immune response |
IC: Inferred by Curator |
GO:0001922 |
P |
||||
| GO:0045732 |
positive regulation of protein catabolic process |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0045736 |
negative regulation of cyclin-dependent protein kinase activity |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0046872 |
metal ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0048662 |
negative regulation of smooth muscle cell proliferation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0050728 |
negative regulation of inflammatory response |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0050869 |
negative regulation of B cell activation |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0060548 |
negative regulation of cell death |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0070429 |
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0070433 |
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0070536 |
protein K63-linked deubiquitination |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
P |
||||
| GO:0070536 |
protein K63-linked deubiquitination |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0070936 |
protein K48-linked ubiquitination |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSP00000237289 |
P |
||||
| GO:0070936 |
protein K48-linked ubiquitination |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0071222 |
cellular response to lipopolysaccharide |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:2000347 |
positive regulation of hepatocyte proliferation |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0045449 |
regulation of transcription |
IMP: Inferred from Mutant Phenotype |
1 |
Fig 1, Fig2. A20/Tnfaip3 induces transcriptional changes at the basal level and after liver resection. |
complete | |||
| GO:0001922 |
B-1 B cell homeostasis |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0002237 |
response to molecule of bacterial origin |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0002315 |
marginal zone B cell differentiation |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0002632 |
negative regulation of granuloma formation |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0002634 |
regulation of germinal center formation |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0002637 |
regulation of immunoglobulin production |
IC: Inferred by Curator |
GO:0001922 |
P |
||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003824 |
catalytic activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0004221 |
ubiquitin thiolesterase activity |
ISS: Inferred from Sequence or Structural Similarity |
F |
|||||
| GO:0004842 |
ubiquitin-protein ligase activity |
ISS: Inferred from Sequence or Structural Similarity |
F |
|||||
| GO:0004843 |
ubiquitin-specific protease activity |
ISS: Inferred from Sequence or Structural Similarity |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0191 |
C |
||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0086 |
C |
||||
| GO:0006915 |
apoptosis |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006916 |
anti-apoptosis |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0008152 |
metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0008233 |
peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008234 |
cysteine-type peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008270 |
zinc ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0009611 |
response to wounding |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0010507 |
negative regulation of autophagy |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0016579 |
protein deubiquitination |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0016787 |
hydrolase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0016874 |
ligase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0019900 |
kinase binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0032495 |
response to muramyl dipeptide |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0032691 |
negative regulation of interleukin-1 beta production |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0032691 |
negative regulation of interleukin-1 beta production |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0032715 |
negative regulation of interleukin-6 production |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0032715 |
negative regulation of interleukin-6 production |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0032715 |
negative regulation of interleukin-6 production |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0032720 |
negative regulation of tumor necrosis factor production |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0034115 |
negative regulation of heterotypic cell-cell adhesion |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0034115 |
negative regulation of heterotypic cell-cell adhesion |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0034148 |
negative regulation of toll-like receptor 5 signaling pathway |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0043154 |
negative regulation of caspase activity |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0045088 |
regulation of innate immune response |
IC: Inferred by Curator |
GO:0001922 |
P |
||||
| GO:0045732 |
positive regulation of protein catabolic process |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0045736 |
negative regulation of cyclin-dependent protein kinase activity |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0046872 |
metal ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0048662 |
negative regulation of smooth muscle cell proliferation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0050728 |
negative regulation of inflammatory response |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0050869 |
negative regulation of B cell activation |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0060548 |
negative regulation of cell death |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0070429 |
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0070433 |
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0070536 |
protein K63-linked deubiquitination |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0070936 |
protein K48-linked ubiquitination |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0071222 |
cellular response to lipopolysaccharide |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:2000347 |
positive regulation of hepatocyte proliferation |
IDA: Inferred from Direct Assay |
P |
| ||||
| edit table |
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 Chu Y et al. (2011) B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 117: 2227-36 PubMed GONUTS page
- ↑ 2.0 2.1 2.2 2.3 Oshima N et al. (2010) A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 159: 185-98 PubMed GONUTS page
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 Wolfrum S et al. (2007) The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes. Proc Natl Acad Sci U S A 104: 18601-6 PubMed GONUTS page
- ↑ Van Huffel S et al. (2001) Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2. J Biol Chem 276: 30216-23 PubMed GONUTS page
- ↑ 5.0 5.1 Coornaert B et al. (2008) T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 9: 263-71 PubMed GONUTS page
- ↑ 6.0 6.1 Iha H et al. (2008) Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. EMBO J 27: 629-41 PubMed GONUTS page
- ↑ Heyninck K et al. (1999) The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol 145: 1471-82 PubMed GONUTS page
- ↑ 8.0 8.1 8.2 8.3 8.4 8.5 Longo CR et al. (2005) A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology 42: 156-64 PubMed GONUTS page
- ↑ 9.0 9.1 Damrauer SM et al. (2010) A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization. Atherosclerosis 211: 404-8 PubMed GONUTS page
- ↑ 10.0 10.1 Shi CS & Kehrl JH (2010) TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal 3: ra42 PubMed GONUTS page
- ↑ 11.00 11.01 11.02 11.03 11.04 11.05 11.06 11.07 11.08 11.09 11.10 11.11 11.12 11.13 11.14 11.15 Hitotsumatsu O et al. (2008) The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28: 381-90 PubMed GONUTS page
- ↑ 12.0 12.1 Zeng W et al. (2009) A20 overexpression inhibits low shear flow-induced CD14-positive monocyte recruitment to endothelial cells. Biorheology 46: 21-30 PubMed GONUTS page
- ↑ 13.0 13.1 Lee EG et al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-4 PubMed GONUTS page
- ↑ Damrauer SM et al. (2011) A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One 6: e17715 PubMed GONUTS page